The halt will remain in place until Tuesday 17th October 2017.
The company’s subsidiary, Harvest One Cannabis Inc, is preparing details regarding the status of its application for a sales amendment to its cultivation license granted under Canada’s Access to Cannabis for Medical Purposes Regulations.
MMJ is focused on becoming a large-scale cannabis producer, targeting direct supply to the growing Canadian medical and recreational markets which will have an estimated combined value of C$8-9 billion by 2024.
The halt will remain in place until the opening of trade on Tuesday 17th October 2017, or earlier if an announcement is made to the market.
ASX:MMJ
Market: ASX
Market Cap: $25.32 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of MMJ Group Holdings Ltd named herein, including the promotion by the Company of MMJ Group Holdings Ltd in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
MMJ Group focuses on strategic vision to be leading cannabis investment company
MMJ Group Holdings Ltd (ASX: MMJ) non-executive director Mike Curtis updates Proactive Investors about its strategic partnership with MMJ operating company Embark Ventures (EBV). The two companies have combined to create the highest quality investments, earnings and share price return for...
on 07/17/2019
2 min read
Prev article
2 min read
